MoneyWorks4Me

The sales for the September 2024 quarter moved up 29.27% to Rs. 900.34 millions as compared to Rs. 696.50 millions during the corresponding quarter last year.The company has announced a 35.57% increase in its profits to Rs . 84.84  millions for the  quarter ended September 2024 compared to Rs. 62.58 millions in the corresponding quarter in the previous year.Operating profit surged to 199.03 millions from the corresponding previous quarter of 154.99 millions.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202409 202309 % Var 202409 202309 % Var 202403 202303 % Var
Sales 900.34 696.50 29.27 1701.13 1371.00 24.08 3071.72 2509.95 22.38
Other Income 2.22 2.34 -5.13 5.00 6.30 -20.63 18.30 29.41 -37.78
PBIDT 199.03 154.99 28.41 375.38 297.02 26.38 684.63 632.29 8.28
Interest 27.07 24.11 12.28 51.85 45.96 12.82 103.87 60.20 72.54
PBDT 171.96 130.88 31.39 323.53 251.06 28.87 509.77 406.80 25.31
Depreciation 46.13 48.77 -5.41 86.32 96.56 -10.60 195.11 149.19 30.78
PBT 125.83 82.11 53.25 237.21 154.50 53.53 314.66 257.61 22.15
TAX 40.99 19.53 109.88 68.70 37.46 83.40 74.83 62.93 18.91
Deferred Tax 0.26 -1.96 -113.27 -0.06 -2.25 -97.33 -4.37 1.37 -418.98
PAT 84.84 62.58 35.57 168.51 117.04 43.98 239.83 194.68 23.19
Equity 103.76 103.76 0.00 103.76 103.76 0.00 103.76 103.76 0.00
PBIDTM(%) 22.11 22.25 -0.66 22.07 21.66 1.86 22.29 25.19 -11.52
Peers
Company Name CMP
Sun Pharma. Inds. 1866.00
Dr. Reddys Labs. 1172.05
Cipla 1372.25
Lupin 2092.00
Zydus Lifesciences 1137.35
View more..